Ekaterina Burygina

Mrs. Ekaterina Burygina

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2015 in Mycoses
Verified
Journal Article
Closed access
PDF file
Nikolai KlimkoNikolai Klimko
Nikolai Klimko
YKY. Kozlova
Y. Kozlova
SKS. Khostelidi
S. Khostelidi
OSOlga Shadrivova
Olga Shadrivova
YBY. Borzova
Y. Borzova
DDD. W. Denning
D. W. Denning

10 December 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
OSOlga Shadrivova
Olga Shadrivova
DGDenis Gusev
Denis Gusev
MVMaria Vashukova
Maria Vashukova
DLDmitriy Lobzin
Dmitriy Lobzin
VGVitaliy Gusarov
Vitaliy Gusarov
WGWorking Group
Working Group
We studied the risk factors, etiology, clinical features and the effectiveness of therapy of COVID-19-associated pulmonary aspergillosis (CAPA) in adult patients. In this retrospective study, we included 45 patients with proven (7%) and probable (93%) CAPA. The ECMM/ISHAM, 2020 criteria were used to diagnose CAPA. A case-control study was conducted to study the risk factors of CAPA; the control group included 90 adult COVID-19 patients without IA. In CAPA patients, the main underlying diseases were diabetes mellitus (33%), and hematological and oncological diseases (31%). The probability of CAPA developing significantly increased with lymphocytopenia >10 days (OR = 8.156 (3.056–21.771), p = 0.001), decompensated diabetes mellitus (29% vs. 7%, (OR = 5.688 (1.991–16.246), p = 0.001)), use of glucocorticosteroids (GCS) in prednisolone-equivalent dose > 60 mg/day (OR = 4.493 (1.896–10.647), p = 0.001) and monoclonal antibodies to IL-1ß and IL-6 (OR = 2.880 (1.272–6.518), p = 0.01). The main area of localization of CAPA was the lungs (100%). The clinical features of CAPA were fever (98% vs. 85%, p = 0.007), cough (89% vs. 72%, p = 0.002) and hemoptysis (36% vs. 3%, p = 0.0001). Overall, 71% of patients were in intensive care units (ICU) (median—15.5 (5–60) days), mechanical ventilation was used in 52% of cases, and acute respiratory distress syndrome (ARDS) occurred at a rate of 31%. The lung CT scan features of CAPA were bilateral (93%) lung tissue consolidation (89% vs. 59%, p = 0.004) and destruction (47% vs. 1%, p = 0.00001), and hydrothorax (26% vs. 11%, p = 0.03). The main pathogens were A. fumigatus (44%) and A. niger (31%). The overall survival rate after 12 weeks was 47.2%.

4 April 2020 in Mycoses
Verified
Journal Article
Closed access
PDF file
YKYana Kozlova
Yana Kozlova
EFEkaterina Frolova
Ekaterina Frolova
AUAleksandra Uchevatkina
Aleksandra Uchevatkina
LFLarisa Filippova
Larisa Filippova
OAOleg Aak
Oleg Aak
NKNikolay Klimko
Nikolay Klimko

29 November 2019 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
OSOlga Shadrivova
Olga Shadrivova
EBEkaterina Burygina
Ekaterina Burygina
Nikolai KlimkoNikolai Klimko
Nikolai Klimko
Objectives: to analyze the results of molecular methods applying for the diagnosis of mucormycosis in hematologic patients based on a literature review. Data sources: A systematic search in databases PubMed, Google Scholar for August 2019. Review eligibility criteria: original articles published in English, studies of molecular methods for the diagnosis of mucormycosis in hematologic patients. Results. We analyzed the research data from 116 hematological patients with mucormycosis, including children (6%). Patients with localized forms of mucormycosis prevailed (72%), and lung involvement was diagnosed in 58% of these cases. For molecular verification of the causative agent of mucormycosis, blood serum was most often used, less commonly postoperative and autopsy material, biopsy specimens, formalin-fixed paraffin-embedded samples and bronchoalveolar lavage, pleural fluid and sputum. The sensitivity of molecular diagnostics of mucormycosis in a cohort of hematological patients was 88.2%. Conclusion. The use of molecular techniques along with standard mycological methods will improve the diagnostics of mucormycosis in hematologic patients. However, prospective studies of the effectiveness of molecular methods for the diagnosis of mucormycosis of various etiologies in hematological patients, including children, using bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) are needed.

13 April 2023 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
EBEkaterina Burygina
Ekaterina Burygina
YKYana Kozlova
Yana Kozlova
EFE.V. Frolova
E.V. Frolova
AUA.E. Uchevatkina
A.E. Uchevatkina
OAO.V. Aak
O.V. Aak
Nikolai KlimkoNikolai Klimko
Nikolai Klimko
АКТУАЛЬНОСТЬ Хроническая спонтанная крапивница (ХСК) — заболевание с гетерогенными иммунопатогенетическими механизмами. Выявление аутоиммунной формы ХСК необходимо для выбора адекватной терапевтической тактики. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить возможности использования в клинической практике теста активации базофилов для диагностики аутоиммунной формы ХСК. МАТЕРИАЛ И МЕТОДЫ В исследование включены 125 пациентов с диагнозом ХСК в возрасте от 18 до 75 лет (медиана 42 года), доля женщин 72,8%. У всех больных оценивали активность крапивницы по шкале UAS7 и функцию щитовидной железы, в периферической крови определяли количество эозинофилов, базофилов и общего IgE, выполняли внутрикожную пробу с аутологичной сывороткой и непрямой тест активации базофилов (ТАБ) методом проточной цитометрии. РЕЗУЛЬТАТЫ Положительный результат ТАБ получен у 43 (34,4%) пациентов с ХСК. Установлена более высокая активность крапивницы ТАБ(+) пациентов по сравнению с ТАБ(-) пациентами (p=0,031), чаще встречались ангиоотеки (p=0,012) и гипотиреоз (p=0,002). В крови отмечен более низкий уровень эозинофилов (p=0,027), базофилов (p=0,026) и общего IgE (p<0,001), а также более высокое содержание антител к тиреоидной пероксидазе (p=0,004). ЗАКЛЮЧЕНИЕ Включение непрямого ТАБ в алгоритм обследования пациентов с ХСК позволит идентифицировать случаи с аутоиммунной формой заболевания в клинической практике.

2 June 2026 in Russian Journal of Allergy
Verified
Journal Article
Open access
ILIrina V. Lyulyu
Irina V. Lyulyu
GMGennady I. Mokhovikov
Gennady I. Mokhovikov
NVNatalya N. Vezikova
Natalya N. Vezikova
AKArtem I. Kurevin
Artem I. Kurevin
EBEkaterina Burygina
Ekaterina Burygina
YKYana Kozlova
Yana Kozlova
BACKGROUND: Severe asthma is a socially significant problem. Despite ongoing therapy, many patients fail to achieve control over their symptoms. Significant interregional differences may exist in both the prevalence and the clinical course of severe asthma. AIM: To assess the clinical and functional features of severe asthma in the Republic of Karelia in a real-world setting. МETHODS: This single-stage, single-center, observational study included 94 adult patients with severe asthma, aged 18 to 75 years (median age 57.5 [49; 66] years): females — 71.3 %. The volume of baseline therapy corresponded to step IV–V according to the clinical guidelines (2024). All patients underwent clinical and laboratory tests, as well as spirometry with a bronchodilator test. The concentration of total immunoglobulin E in the blood serum was determined by enzyme immunoassay. The Russian-language versions of the Asthma Control Questionnaire and Asthma Control Test questionnaires were used. RESULTS: The majority of patients were identified with the T2 endotype of airway inflammation (94.6 %), and sensitization to ≥1 allergen was present in 58.5 % of cases. Uncontrolled course was established in 63 (67%) patients. The rate of corticosteroid-dependent asthma was 14.8 %. The main comorbid conditions were: allergic rhinitis — 48.9 % of patients, chronic rhinosinusitis with nasal polyps — 32.9 %, and atopic dermatitis — 13.8 %. Obesity was diagnosed in 49 (52.1 %) patients. Biologic therapy for more than 12 months was received by 15 (15.9 %) patients. CONCLUSION: Patients with severe asthma in the Republic of Karelia are characterized by an uncontrolled disease course, a predominance of the T2 endotype of airway inflammation, and the presence of T2-associated multimorbid pathology.